Nagarjuna Fertilizers delays FY26 results to June 15
Nagarjuna Fertilizers and Chemicals Limited has delayed the submission of its audited financial results for the year ended March 31, 2026, to June 15, 2026, due to unprecedented employee attrition in critical positions caused by financial difficulties. The company was originally required to file the results by May 30, 2026, under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The departure of key personnel has hampered the preparation and finalization of periodical reporting.

*this image is generated using AI for illustrative purposes only.
Nagarjuna Fertilizers and Chemicals Limited has announced a delay in the submission of its audited financial results for the year ended March 31, 2026, citing unprecedented employee attrition in critical positions due to financial difficulties. The company is now scheduled to file the results on or before June 15, 2026. This postponement impacts the timely disclosure of its annual financial performance to the exchanges.
Under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company was obligated to submit the audited financial results within 60 days from the end of the financial year, specifically by May 30, 2026. The inability to meet this regulatory deadline stems from operational challenges in finalizing periodical reporting caused by the departure of key personnel.
Reasons for Delay
The company explicitly stated that financial difficulties have led to significant staff attrition, which has hampered the preparation and finalization of the financial statements. The loss of employees in critical roles has created a bottleneck in the reporting process, necessitating an extension to ensure accurate results.
Revised Timeline
Nagarjuna Fertilizers and Chemicals Limited has committed to finalizing the audited financial results and submitting them to the stock exchanges by the new deadline of June 15, 2026. The company has requested the exchanges to take this revised schedule on record.
| Event | Original Date | Revised Date |
|---|---|---|
| Financial Year End | March 31, 2026 | March 31, 2026 |
| Regulatory Deadline | May 30, 2026 | June 15, 2026 |
What specific measures is the company taking to retain or replace critical personnel to prevent further operational disruptions?
How will this delay impact investor confidence and the company's stock price in the short term?
Could the financial difficulties leading to attrition signal deeper liquidity or solvency issues for the company?

































